Atacicept Terminated Phase 2 Trials for IgA Nephropathy (IgAN) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02808429Efficacy and Safety of Atacicept in IgA Nephropathy